CSBR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CSBRChampions Oncology, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

CSBRChampions Oncology, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CSBRChampions Oncology, Inc.

4.87· pre 4.87· delayed

Mkt cap$67.2MRevenue$15MQ1 FY27Revenue$59MFY26

AMGNAmgen Inc

460.67· pre 463.52· delayed

Pre-marketNov 4 '26delayed

Mkt cap$249.4BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 4 '26delayed

CSBRChampions Oncology, Inc.

AMGNAmgen Inc

4.87pre 4.87delayed

Price

460.67pre 463.52delayed

$67.2M

Mkt cap

$249.4B

Q1 FY27$15M

Revenue

$10.1BQ2 FY26

FY26$59M

Revenue

$36.8BFY25

CSBR4.87vsAMGN460.67Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CSBR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CSBR 1

MARMarriott Internationalcustomer

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customerSource: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

CSBR, solidAMGN, dashed